Virax is to a receive a milestone payment from their Co-X-Gene Technology licence agreement with Transgene (France) thanks to Transgene's partnership agreement with Roche.
From Transgene's announcement, it looks as though further payments can be expected in both the short and long term.
Further confirmation of Transgene's product utilising the technology will support Virax in their proof of product.
Add to My Watchlist
What is My Watchlist?
